- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NMAB is the preeminent source of independent materials assessments for the U.S.
nGimat, a leading manufacturer and innovator of engineered nanomaterials, today announced that its CEO, Dr. Andrew Hunt, has been appointed to the National Materials Advisory Board (NMAB). The NMAB is the preeminent source of independent materials assessments for the U.S. and is part of the National Research Council's (NRC) Division on Engineering and Physical Sciences (DEPS).
“The NMAB is excited to have added Dr. Hunt to its membership,” said Gary Fischman, director of the NMAB. “His technical knowledge of coating and nanopowder production as well as his clear understanding of the issues underlying the development and growth of a small materials-based business will be extremely valuable to our group. We welcome him and look forward to his active involvement on the Board.”
“As demand and production of nanoscale materials continues to grow, the NMAB plays an increasingly critical role in providing independent analysis,” said Dr. Hunt. “It’s an honor to serve on the NMAB along with esteemed colleagues from business, education and government sectors.”
The NMAB studies deal with the entire life cycle of materials, from mining and synthesis to manufacturing, service performance and recycling/disposal. They achieve a balanced view by having access to the expertise of all sectors of society concerned with materials. Board assessments of new materials and processing methods focus attention on policy issues with significant technology content and its activities create broader awareness and advocacy for materials issues. The National Research Council is part of the National Academies, which also comprise the National Academy of Sciences, National Academy of Engineering and Institute of Medicine. They are private, nonprofit institutions that provide science, technology and health policy advice under a congressional charter.
For more information about the NMAB see:
nGimat Co. is a cost-effective manufacturer and innovator of engineered nanomaterials in the following areas: nanopowders, thin films and devices. nGimat's Combustion Chemical Vapor Deposition (CCVD) and NanoSpraySM Processes along with its Nanomiser® Device enable synthesis of nanoparticles and thin films. These processes are easily scalable, thereby enabling low-cost production of engineering materials with controlled composition, size, and morphology. nGimat’s product development, sales and licensing is focused in four target markets: 1) nanopowders and process, 2) barrier coatings, 3) electronic and optical coatings and devices, and 4) RF wireless components. nGimat offers its commercial customers product sales, license arrangements, and R&D services. nGimat also has an active program of government development grants from agencies such as the National Science Foundation, the Department of Energy, the Department of Defense (Navy, Army, Air Force and Missile Defense Agency), the National Institute of Health, the Environmental Protection Agency, and NASA. The CCVD and NanoSpraySM Processes, along with the Nanomiser® Device, for nanopowders and coatings, were invented by nGimat's founder, Dr. Andrew Hunt. nGimat has more than 30 issued U.S. patents and, numerous foreign patents and multiple patent applications covering its raw materials, processes, equipment, composition of matter, intermediate products and final products.
For more information, please visit www.ngimat.com
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Graphene leans on glass to advance electronics: Scientists' use of common glass to optimize graphene's electronic properties could improve technologies from flat screens to solar cells February 12th, 2016
Breaking cell barriers with retractable protein nanoneedles: Adapting a bacterial structure, Wyss Institute researchers develop protein actuators that can mechanically puncture cells February 12th, 2016
Properties of Polymeric Nanofibers Optimized to Treat Damaged Body Tissues February 12th, 2016
Semblant Appoints Donald Cunningham as Chief Commercial Officer January 2nd, 2016